IRF5 and systemic lupus erythematosus: Somewhat distinct from the cTfh subset, we detected increased percentages of circulating Tfr cells in both SLE patients and IRF5 risk carriers, which was unexpected since Tfr cells are known to suppress Tfh function and GC response [13,15].